Impact Of Rising Birth Rates On Rotavirus Vaccine Market Growth Is Supporting Development Across The Rotavirus Vaccine Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Rotavirus Vaccine Market Compare Between 2026 And 2030?

The rotavirus vaccine market size has experienced rapid growth in recent years. It is anticipated to expand from $10.14 billion in 2025 to $11.2 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.4%. The historical surge in this market can be attributed to an increased incidence of pediatric gastroenteritis, the expansion of national immunization schedules, the growth of public health vaccination campaigns, the availability of live attenuated vaccines, and rising awareness of rotavirus prevention.

The rotavirus vaccine market size is projected to undergo substantial expansion over the next few years. It will grow to $16.45 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. This growth during the forecast period can be attributed to factors such as the increasing demand for universal pediatric vaccination, the expansion of combination vaccine development efforts, rising investments in vaccine manufacturing capacity, a growing focus on global immunization coverage, and increasing collaboration with public health agencies. Key trends in the forecast period are expected to include the expanding implementation of pediatric immunization programs, the rising adoption of oral vaccine formulations, an increasing emphasis on optimizing the vaccine cold chain, the broadening of public health vaccination initiatives, and enhanced surveillance of rotavirus infections.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20617&type=smp

Which Major Factors Are Contributing To The Development Of The Rotavirus Vaccine Market?

An anticipated increase in birth rates is projected to drive the expansion of the rotavirus vaccine market in the future. Birth rates define the count of live births occurring within a population for every 1,000 people during a defined duration, usually calculated yearly. These rates are impacted by improved economic conditions and progress, alongside supportive government initiatives like parental leave, child benefits, and childcare subsidies. The administration of rotavirus vaccines contributes to lowering the occurrence of severe rotavirus gastroenteritis among infants, consequently enhancing children’s health and decreasing medical expenditures linked to rotavirus infections. For example, data from a January 2023 report by the Centers for Disease Control and Prevention, a US-based national public health entity, showed that the United States experienced a 1% rise in recorded births, reaching a total of 3,664,292, when compared to the prior year. Consequently, an upward trend in birth rates is set to fuel the expansion of the rotavirus vaccine market.

How Is Segment Classification Applied In The Rotavirus Vaccine Market?

The rotavirus vaccine market covered in this report is segmented –

1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types

2) By Application: Adult, Pediatric

3) By End Users: Hospitals, Clinics, Academic Research

What Trends Are Influencing The Rotavirus Vaccine Market?

Leading companies within the rotavirus vaccine market are integrating oral-dosing applicators to improve vaccine delivery effectiveness and boost patient adherence. Oral-dosing applicators are medical instruments crafted to dispense liquid medications or vaccines directly into the mouth, ensuring accurate measurement and ease of application, particularly for infants and young children. For example, in June 2025, Micron Biomedical, a U.S.-based biotechnology company, and Emory University, a U.S.-based private university, commenced a first-in-human clinical trial for the inactivated rotavirus vaccine CC24, administered via a dissolvable microarray patch. This patch is thermostable, reducing dependence on cold chain infrastructure, allows for self-administration, and generates no sharps waste. This advancement shows promise for increasing vaccine access in low-resource areas, although regulatory pathways are still unproven, and potential scale-up challenges might hinder its widespread adoption in the rotavirus vaccine market.

Who Are The Major Companies Operating In The Rotavirus Vaccine Market?

Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd

Access The Complete Rotavirus Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/rotavirus-vaccine-global-market-report

Which Region Commands The Largest Share Of The Rotavirus Vaccine Market?

North America was the largest region in the rotavirus vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Rotavirus Vaccine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=20617&type=smp

Browse Through More Reports Similar to the Global Rotavirus Vaccine Market 2026, By The Business Research Company

Meningococcal Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report

Swine Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Typhoid Vi Polysaccharide Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795